$TXN

UBS Adjusts Texas Instruments Price Target to $360 From $380, Maintains Buy Rating

UBS lowered its price target for Texas Instruments (TXN) from $380 to $360 but maintained a buy rating. The stock is currently trading at $282.24, up 62.64% year-to-date. Rosenblatt Securities also adjusted its target to $360 from $350.

Original reporting
Published Oct 22, 2026, 1:49 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 22, 2026, 2:30 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$TXN
Bearish
high confidence
Mentioned
$TXN
Relevance
7/10
AlphAI data visualization · based on marketscreener.com
Decision brief

The 30-second read

$TXNBearishMed
01

Why it matters

The downgrade signals a shift in valuation expectations, potentially prompting short‑term sell pressure.

02

Market read

Analyst target adjustments are closely watched by traders; a cut may trigger immediate price action.

03

What to watch

Recent contract wins or supply‑chain improvements that UBS may not have fully incorporated.

Relevance 7/10Novelty 7/10Timing: pre‑market today

Background

UBS published a revised price target for Texas Instruments, lowering it by $20, while maintaining a buy rating.

Company-level read

Ticker impact

$TXNBearishHigh confidence
Context

UBS lowered Texas Instruments' price target to $360 from $380, indicating a fresh analyst downgrade.

Expected impact

downward pressure as the market prices in the reduced target.

Evidence & confidence

Analyst target cuts historically precede short-term price declines, especially when the downgrade is sizable.

Market effects

May weigh on the broader semiconductor sector as peers could face similar valuation pressure.

Limited to U.S. markets where Texas Instruments is a major component of tech indices.

Minimal global effect beyond U.S. tech exposure.

Counterpoint

The target cut could be overly pessimistic if recent product launches exceed expectations.

Key entities

  • Texas Instruments

    U.S. semiconductor manufacturer (ticker TXN).

  • UBS

    Global investment bank providing the price target revision.

Related articles

$TXNMedAI 8/10

Texas Instruments Stocks Slip Despite Broad Chip Recovery

Texas Instruments reported Q3 revenue of $6.06B and EPS of $2.62, with shares down 1.20% on Oct 22. Sales grew 28% YoY and 11% QoQ, driven by industrial, automotive, and data-center sectors. Management forecasts Q4 revenue between $5.80B-$6.30B and EPS between $2.45-$2.79. Shares trade 17.07% above GF Value estimate.

$TXNHigh

Texas Instruments stock rating upgraded at Freedom Broker on margins

Freedom Broker upgraded Texas Instruments (TXN) to Buy, raising its price target to $330. The firm cited strong Q3 results, with revenue and margins beating expectations. TXN's revenue grew 17% YoY, and it raised its dividend for 23 consecutive years. Analysts highlight demand in industrial, data center, and automotive sectors, with mixed price target adjustments.

$TXNHighAI 8/10

Texas Instruments earnings analysis: questions answered and next catalysts

Texas Instruments (TXN) reported Q3 FY2026 earnings with EPS of $2.62 (beating estimates by 8.26%) and revenue of $6.06B. The stock is trading at $281.10, 16% below its 52-week high. Revenue grew 28% YoY, with data center revenue up 95%. Gross margin reached 64%. Q4 guidance is $5.8B–$6.3B revenue and $2.45–$2.79 EPS. Analysts have mixed views on valuation and future growth.

$TSLAMed

Tesla Will Make Millions of Optimus Robots. Texas Instruments Can Get Paid on Every One

Tesla (TSLA) began production of Optimus robots in Fremont, aiming for millions, but disclosed no unit volumes. Texas Instruments (TXN) reported chip content of $500-$1,000 per humanoid robot, without naming Tesla as a customer. TI closed at $284.65, up 2.47%, and Tesla at $386.47, up 3.41%. TI's robotics revenue could reach $500M-$1B annually, but faces competition and Tesla's in-house silicon plans.